These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 841671)

  • 1. Detection of HBsAg in coagulation Factor IX concentrates.
    O'Connor ML; Meek ES; Simmons A
    Transfusion; 1977; 17(1):44-6. PubMed ID: 841671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor IX levels in patients with hemophilia B (Christmas disease) following transfusion with concentrates of factor IX or fresh frozen plasma (FFP).
    Zauber NP; Levin J
    Medicine (Baltimore); 1977 May; 56(3):213-24. PubMed ID: 859444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of hepatitis B surface antigen in commercially prepared plasma products.
    Hoofnagle JH; Gerety RJ; Thiel J; Barker LF
    J Lab Clin Med; 1976 Jul; 88(1):102-13. PubMed ID: 932529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serologic evidence of hepatitis B virus infection in patients with hemophilia B. a multicenter study.
    Hoofnagle JH; Aronnon D; Roberts H
    Thromb Diath Haemorrh; 1975 Jun; 33(3):606-9. PubMed ID: 1154315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Removal of hepatitis B surface antigen (HBsAg) from plasma fractions.
    Johnson AJ; Semar M; Newman J; Harris RB; Brandt D; Middleton S; Smith J
    J Lab Clin Med; 1976 Jul; 88(1):91-101. PubMed ID: 932537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of HBsAg and post-transfusional hepatitis type B.
    Bedarida G; D'Agostino F; Lavezzi C; Tamagni F
    Boll Ist Sieroter Milan; 1978 May; 57(2):160-4. PubMed ID: 728267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus and hepatitis B surface antigen in human albumin products.
    Hoofnagle JH; Barker LF; Thiel J; Gerety RJ
    Transfusion; 1976; 16(2):141-7. PubMed ID: 1258115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of viral hepatitis after administration of factor IX concentrates.
    Iwarson S; Kjellman H; Teger-Nilsson AC
    Vox Sang; 1976; 31(2):136-40. PubMed ID: 951972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-its derivatives and its problems--factor IX.
    Kasper CK
    Ann N Y Acad Sci; 1975 Jan; 240():172-80. PubMed ID: 1089381
    [No Abstract]   [Full Text] [Related]  

  • 10. Post-transfusion hepatits following the use of prothrombin complex concentrates.
    Roberts HR; Blatt PM
    Thromb Diath Haemorrh; 1975 Jun; 33(3):610-6. PubMed ID: 1154316
    [No Abstract]   [Full Text] [Related]  

  • 11. Concentration of hepatitis-B antigen from clinical preparations of II, VII, IX and X by polyethylene glycol, to enhance detection and removal.
    Johnson AJ
    Ann N Y Acad Sci; 1975 Jan; 240():162-4. PubMed ID: 234215
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of prothrombin complex concentrates in hemophiliacs with inhibitors: clinical and laboratory studies.
    Buchanan GR; Kevy SV
    Pediatrics; 1978 Nov; 62(5):767-74. PubMed ID: 724319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Present and future trends in the laboratory diagnosis of viral hepatitis.
    Taylor PE
    Dev Biol Stand; 1975; 30():41-54. PubMed ID: 812747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prothrombin complex concentrate (Konyne) in the treatment of hemophilic patients with factor VIII inhibitors.
    Abildgaard CF; Britton M; Harrison J
    J Pediatr; 1976 Feb; 88(2):200-5. PubMed ID: 1249680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis, type B in haemophiliacs. Relation to the source of clotting factor concentrates.
    Holsteen V; Skinhoj P; Cohn J
    Scand J Haematol; 1977 Mar; 18(3):214-8. PubMed ID: 847395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jaundice and hepatitis B antigen-antibody in hemophilia.
    Lewis JH; Maxwell NG; Brandon JM
    Transfusion; 1974; 14(3):203-11. PubMed ID: 4835949
    [No Abstract]   [Full Text] [Related]  

  • 17. Improved detection of hepatitis B surface antigen (HBsAg) in blood donors by monoclonal radioimmunoassay.
    Ben-Porath E; Wands JR; Bar-Shany S; Huggins C; Isselbacher K
    Transfusion; 1985; 25(1):10-4. PubMed ID: 3969695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis risk in cardiac surgery patients receiving factor IX concentrates.
    Rossiter SJ; Miller DC; Raney AA; Oyer PE; Reitz BA; Stinson EB; Shumway NE
    J Thorac Cardiovasc Surg; 1979 Aug; 78(2):203-7. PubMed ID: 459527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunoassay for the detection of HBeAg and anti-HBe.
    Zanetti AR; Ferroni P; Bonino F; Recchia S; Aricò S; Palla M; Caspani B
    Boll Ist Sieroter Milan; 1979 Jan; 57(6):811-5. PubMed ID: 95390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative detection and typing of HBs Ag and anti-HBs by radioimmunoassay techniques.
    Petrilli FL; Crovari P; De Flora S
    Dev Biol Stand; 1975; 30():103-110. PubMed ID: 1204946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.